Generic/Discount HIV Drug Access in the Developing World
- Price Reporting Mechanism (Regularly Updated)
An online tool aimed at helping developing countries secure the lowest possible prices on HIV medications and other drugs and equipment.
From Global Fund to Fight AIDS, Tuberculosis and Malaria - Clinton Foundation Secures Big Price Cuts for Second-Line Generics (May 8, 2007)
From aidsmap.com - India's Decision to Adhere to International Patent Regulations Could Limit Access to Medicines, Including HIV/AIDS Drugs (January 8, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Free Trade, Expensive Drugs (Fall 2006)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America - FDA Tentatively Approves Generic Pediatric d4T for PEPFAR (December 22, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - U.S. Formally Accepts WTO Amendment Allowing Developing Countries to Import Generic HIV Medications (December 19, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - WHO Adds Seven Antiretrovirals to List of Prequalified HIV Drugs (December 15, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - HIV Treatment as Successful in Haitian Patients as U.S. Patients (December 1, 2005)
Study in New England Journal of Medicine supports distribution of antiretrovirals in resource-poor countries.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Médecins Sans Frontières Urges Drug Companies to Boost Development of Low-Cost Antiretrovirals for Children (November 30, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Brazil Nears New Deal With Abbott on Price of Kaletra (October 4, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Free Antiretrovirals in Developing World Should Be Given to All Patients, Not Just Treatment-Naive Patients, Experts Say (October 2005)
In PLoS Medicine - Gilead Lowers Its No-Profit Drug Prices for Truvada, Viread (August 30, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Two Nations Unite on AIDS Care: Argentina, Brazil Vow to Make Generic Drugs (August 25, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Global Fund Provides HIV/AIDS Drugs for 90,000 More People in First Six Months of 2005 (August 23, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Indian Generic Drug Firm Ranbaxy Announces Seven Antiretroviral Drugs Reinstated to WHO-Approved List (August 16, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - House Passes Central American Free Trade Agreement; AIDS Advocates Say Agreement Could Threaten Treatment Access (July 28, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Clinton Launches Programs to Put More HIV-Positive Children on Antiretroviral Treatment in Kenya, Rwanda (July 25, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Resistance to Thai-Made Antiretroviral GPO-vir (Lamivudine/Nevirapine/Stavudine) Sharply Increasing (July 19, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Abbott Agrees to Kaletra Pricing Deal in Brazil; Government Drops Threat to Break Patent (July 11, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Brazil in Last-Minute Talks With Abbott on Antiretroviral Drug Prices; Country Might Break Patent If No Agreement (July 8, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - HIV JournalView: Exporting Lipodystrophy: d4T Usage in Developing World (July/August 2005)
From The Body PRO - Ranbaxy Gets U.S. FDA Approval for Generic AIDS Drug (May 31, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Efavirenz, Stavudine Demand May Soon Exceed Supply in Developing World (March 4, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Are We In It for the Long Haul? (March/April 2005)
Precious few resources are being put toward addressing both the short-term and long-term needs surrounding HIV treatment in the developing world, Gregg Gonsalves says.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Treat the World: Why Global HIV Treatment Access Isn't Easy to Achieve (March/April 2005)
In GMHC Treatment Issues, from Gay Men's Health Crisis - World CAB II: Discussing Generic Drug Availability (March/April 2005)
Condensed excerpts from a January 2005 meeting in Mumbai, India, between generic drug makers and global HIV treatment advocates.
In GMHC Treatment Issues, from Gay Men's Health Crisis - India Changes Patent Law to Meet WTO Treaty, Making New Medicines Less Available to Most Citizens, Other Countries (December 31, 2004)
In AIDS Treatment News, from AIDS Treatment News - Why the Meds Should Wait: An African AIDS Advocate Speaks Out (July 15, 2004)
AIDS advocate and former African resident Colin Webb argues that we should not be trying to deliver life-saving HIV meds to Africa before the continent has an effective health infrastructure in place.
In International Herald Tribune - Developments on Generic, Fixed-Dose Combination Antiretrovirals Reported (July 14, 2004)
Accelerated development of a Combivir/nevirapine pill; generic drug production in Thailand; a South African patent for Triomune.
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - HAART Has Dramatically Improved Survival Rates in Developing World, Study Finds (July 14, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - U.S. Global AIDS Coordinator Tobias Addresses XV International AIDS Conference (July 14, 2004)
Tobias defends U.S. policies on generic antiretrovirals for the developing world; his speech was interrupted by protestors.
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - WHO Approves New Generic Lamivudine, Fluconazole Pills (July 14, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - One World, Multiple Standards (July 2004)
In the push for greater HIV treatment access worldwide, we must not lose sight of the other important issues in HIV care, writes José Zuniga.
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Protest Photos From the XIII International AIDS Conference in Durban, South Africa (July 2004)
How much progress has been made toward global HIV treatment access since the last International AIDS Conference to be held in a developing country?.
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Stern Words For Pfizer (July 2004)
Pfizer's drug-pricing policies in Latin America "border on genocidal," writes Richard Stern, Director of the Agua Buena Human Rights Association.
In TAGline, from Treatment Action Group - WHO Removes Cipla's Lamivudine, Zidovudine Generics From Approved Drug List (June 16, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Zimbabwe Drug Company May Be Africa's First to Produce Generic Antiretrovirals (June 9, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Jamaica Signs Global Fund Agreement to Receive Reduced-Cost Antiretrovirals (May 19, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - UN Health Bodies Welcome Revised U.S. Guidelines on AIDS Treatments (May 18, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - U.S. to Start Fast-Track Review Program for Generic HIV Drugs, Fixed-Dose Combinations (May 17, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - HHS Proposes Rapid Process for Review of Fixed Dose Combination and Co-Packaged Products (May 16, 2004)
Press release of a statement from U.S. officials.
From U.S. Department of Health and Human Services - Global HIV Treatment Access Pivotal to Altering Course of Epidemic, WHO Report Says (May 12, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Canadian House of Commons Unanimously Approves Bill to Allow Manufacture of Generic AIDS, Other Drugs for Africa (May 5, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Progress on Antiretroviral Access in India: Interview With Khousalya Periaswamy (May/June 2004)
Ms. Periaswamy is the president of the Positive Women's Network, an AIDS advocacy/service organization in India.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Canadian Lawmakers Introduce Amendments to Bill That Would Allow Manufacture of Generic Drugs for Africa (April 21, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - President's Plan Would Limit Access to Effective, Low-Cost Generic AIDS Drugs in Developing Countries (April 19, 2004)
- Clinton Foundation, Global Fund, World Bank, UNICEF Extend Low-Cost Generic AIDS Drug Prices to More Than 100 Countries (April 6, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Bush Loyalty to Brand-Name Drugs Could Cost Overseas HIV Treatment Programs (March 29, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - International AIDS Conference in Thailand Will Focus on Treatment Access (March 22, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Global Alliance Doubles Number of Africans on HIV Treatment (March 19, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Nigeria's AIDS Program Said Back on Track (March 16, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Brazil: Agreement Reached on Discounts for Five Antiretrovirals (January 16, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Zambia to Add 100,000 Patients to HIV Treatment Program (January 16, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Clinton Foundation Deal Will Reduce Price of Viral Load, CD4+ Tests for Developing Countries by as Much as 80% (January 15, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Interview With Joep M. A. Lange, M.D., Ph.D., on Treatment Access in the Developing World (Winter 2003/2004)
Dr. Lange is President of the International AIDS Society; both a transcript and audio of this interview are available.
In Positives for Positives, from Wyoming: Positives for Positives - WTO Agreement Over Generic Drug Access May Not Ensure Immediate Availability of Drugs (September 9, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Brazil Authorizes Importation of Generic AIDS Drugs; Move Could Reignite WTO Debate (September 5, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - World Trade Organization Agrees on Deal to Allow Developing Countries to Import Generic Drugs (September 2, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Brazil Threatens to Break Patents, Produce Antiretroviral Drugs if Companies Do Not Reduce Prices (August 29, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - WTO Executive General Council Delays Decision on Access to Generic Drugs Agreement (August 29, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - WTO Deal on Generic Drug Access for Developing Countries Close; Agreement Could Prevent Breakdown of Trade Talks (August 28, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Brazil Threatens to Break AIDS Drugs Patents (August 4, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Uganda, Botswana Only African Countries Participating in Boehringer Ingelheim Free Antiretroviral Drug Program (July 15, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Bush Supports Moratorium on Global Patent Laws for HIV Drugs (July 10, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - U.S. Drops Its Demand for List of Diseases Covered by Drugs Agreement (June 24, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Warning Over Drug-Resistant HIV (June 20, 2003)
The unregulated supply of HIV drugs in the developing world threatens to accelerate the development of drug-resistant HIV strains.
From BBC News - Technology Transfer Will Allow Countries to Produce Own TB Drugs (June 5, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Glaxo Will Further Cut Prices of AIDS Drugs to Poor Nations (April 28, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Haiti, Small Caribbean Islands to Get Cheaper HIV/AIDS Drugs (April 28, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Namibia Welcomes Price Cuts for Antiretrovirals (April 25, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - AIDS Group Refiles Drug-Patent Challenge (April 24, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Burkina Faso to Purchase Generic AIDS Drugs From Indian Company (April 23, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Lebanon: AIDS Drug Deal to Slash Treatment Costs (April 21, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Gilead Offers Tenofovir to Developing Countries at Cost (April 4, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - India's Anti-AIDS Drugs Look for More Takers (March 24, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Tenofovir (Viread) Access for Poor Countries (December 20, 2002)
In AIDS Treatment News, from AIDS Treatment News - U.S. Blocks Trade Agreement on Generic Drug Access in Poor Countries (December 20, 2002)
In AIDS Treatment News, from AIDS Treatment News - Drug Patents and Developing Countries: Problems Remain (November 22, 2002)
In AIDS Treatment News, from AIDS Treatment News - Antiretroviral Treatment Regimens Suitable for Resource-Poor Settings (November 18, 2002)
In The 6th International Congress on Drug Therapy in HIV Infection, from The Body PRO - World Trade Organization Meeting Fails to Resolve Major Issues on Generic Drugs (November 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Progress in Doubt on Drug Patents at World Trade Organization Summit (November 14, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Pharmaceutical Giant to Let Generic Company Manufacture Its AIDS Drug (October 15, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Thailand: Patients, Advocates Sue to Invalidate Videx EC Patent (October 10, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - U.S. and World Trade Organization Negotiate Drug Access (September 30, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - From Marrakech to Doha: Some Reflections on the Foundations of Patent Regime in Pharmaceutical Industry (July 8, 2002)
In The XIV International AIDS Conference, from The Body PRO - The Creation of a Non-Voluntary Patent Pool for Essential HIV Inventions (July 8, 2002)
In The XIV International AIDS Conference, from The Body PRO - Private Sector Responses: Taking Care of Our Own (July/August 2002)
Why Heineken decided to offer anti-HIV medications to its East African employees and their families.
In GMHC Treatment Issues, from Gay Men's Health Crisis
  |